An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.Scott R. Burrows, Denis J. Moss, Rajiv Khanna et al.|The Journal of Experimental Medicine|1994Cited by 276
T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I–bound peptideFleur E. Tynan, Jamie Rossjohn, Scott R. Burrows et al.|Nature Immunology|2005Cited by 267
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronavirusesKatie E. Lineburg, Stéphanie Gras, Emma J. Grant et al.|Immunity|2021Cited by 206
Cross‐reactive memory T cells for Epstein‐Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex‐bound peptide by T cells and its role in alloreactivityScott R. Burrows, Denis J. Moss, Sharon L. Silins et al.|European Journal of Immunology|1997Cited by 169
Defective T‐cell control of Epstein–Barr virus infection in multiple sclerosisMichael P. Pender, Scott R. Burrows, Peter A. Csurhes et al.|Clinical & Translational Immunology|2017Cited by 139